Wan Chai, Hong Kong, September 24, 2014 -- Human immune systems can be induced to respond against cancer using a range of approaches including autologous immune cells. Immune cell based therapies are demonstrating much promise as potential therapies for cancer in recent studies and the only noninvasive treatment option for advanced cancers. Even more surprising is that similar to laser therapy, immune based therapies are being utilized in conjunction with stem cells in the most modern stem cell clinics. In immune cell therapies, autologous patient leukocytes are isolated and manipulated in vitro before transfer back, as dendritic cells (DCs) or activated cytotoxic T lymphocytes (CTLs).

Researchers have shown that fresh and vital dendritic cells can be introduced into the body in the form of a vaccine. If cancer is present, inoculation with new dendritic cells alerts the immune system to the presence of cancer and restarts proper immune function. This serves to mobilize the exceptional power of the immune system to identify Cancer and combat it. These dendritic cells are cultured from the patient’s own white blood cells (so they are described as “autologous”. Initially, after a simple blood draw, the blood is sent to a high-tech medical laboratory where specially trained cell biologists and technicians separate out certain white blood cells (monocytes) from the blood. These cells are then cultured and transformed in seven days into a new generation dendritic cells. This new generation of vital, activated dendritic cells is re-introduced into the patient’s body through simple intractaneous injections as shown above. The results are remarkable by any standard, increasing immune response, patient survival, and quality of life.

According to Don Margolis, the Chairman of LEmed, "This approach harnesses the power of the immune system by recruiting the body’s own specific immune cells that can recognize and then marshal an attack against foreign invaders and diseased cells. In theory, malignant cells should be ideal targets for immune cells, but tumors have ways of shielding themselves from our immune attack. With our new immune cell based therapies, we aim to restore these crucial defending lines against the tumors. All this without the devastating side effects of chemo and radiation!"

Further, Mr. Margolis revealed that he has associated LEmed with two stem cell clinics already treating patients with immune-based therapies, one in Asia and one in North America. But his most surprising revelation was that both of these established stem cell hospitals are using T-Cells and Dendritics along with stem cells to treat Renal failure, MS, Parkinson, and Lupus in addition to Cancer. Anyone wishing to learn more about these two clinics need only email Mr. Tobin at LEmed.

About Leading Edge Medical Ltd.:
Cellular medicine is revolutionizing medical treatment in the 21st century and Leading Edge Medical's treatments are at the forefront of the field. Thousands of patients around the world have already benefited from bio-technologies using stem cells and intravenous laser therapy. Diseases once considered incurable are responding well to stem cell therapies and are restoring a quality of life to patients they thought they had lost forever.

LEmed is committed to applying modern day best practices to the growing field of regenerative medicine. With advanced medical treatment facilities offering personalized, ongoing care plans and the highest quality of customer service, we are dedicated to providing a better life for patients.

Contact:
Jeffery Tobin
Client Services Director
Leading Edge Medical, Ltd
14F, 8 Hennessy Road
China Hong Kong Tower
Wan Chai, Hong Kong, 999077
+852 21270684
[email protected]
http://www.healingmed.com